An effective strategy for the targeted delivery of new antimalarials
Xavier Fernàndez Busquets’ joint IBEC-ISGlobal Nanomalaria group has moved a step closer to the validation of immunoliposomes as a vehicle for antimalarial drugs by showing that they increase the efficacy of lipohilic (poorly soluble) compounds in a mouse model of malaria.
The results, published in Biomaterials, suggest that this strategy could be used for the treatment of severe malaria.
Most antimalarial drugs currently in the pipeline are poorly soluble in water, and high amounts are needed to ensure their efficacy, particularly in cases of severe malaria.
Yesterday and today IBEC has been exhibiting at the Coventry Life Festival in the UK, a celebration of active ageing which is taking place in the university town not far from Birmingham.